Gilead Sciences, Inc. GILD
NASDAQ · United States · Health Technology
$149.05-2.23 (-1.47%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -6.75 | -7.25 | +6.9% | $7.80B | +5.5% | +0.5%$131.15→$131.76 |
| Q1 2026 | 2026-05-07 | 2.03 | 1.91 | +6.3% | — | — | -3.6%$136.30→$131.33 |
| Q4 2025 | 2026-02-10 | 1.86 | 1.81 | +2.8% | — | — | +2.7%$151.68→$155.80 |
| Q3 2025 | 2025-10-30 | 2.47 | 2.14 | +15.4% | — | — | +1.1%$118.50→$119.79 |
| Q2 2025 | 2025-08-07 | 2.01 | 1.96 | +2.6% | — | — | — |
| Q1 2025 | 2025-04-24 | 1.81 | 1.78 | +1.7% | — | — | — |
| Q4 2024 | 2025-02-11 | 1.90 | 1.70 | +11.8% | — | — | — |
| Q3 2024 | 2024-11-06 | 2.02 | 1.55 | +30.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.